Tetrazolyl-phenyl acetamide glucokinase activators

Details for Australian Patent Application No. 2001283998 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Sidduri, Achyutharao

Agent Spruson & Ferguson

Pub. Number AU-B-2001283998

PCT Pub. Number WO02/14312

Priority 60225494 15.08.00 US

Filing date 9 August 2001

Wipo publication date 25 February 2002

Acceptance publication date 20 October 2005

International Classifications

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 031/4427 - containing further heterocyclic ring systems

C07D 257/04 Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

A61P 003/10 Drugs for disorders of the metabolism

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 031/427 - not condensed and containing further heterocyclic rings

Event Publications

20 October 2005 Application Accepted

  Published as AU-B-2001283998

16 February 2006 Standard Patent Sealed

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001283999

2001283997